Immunoblastic Lymphadenopathy. Evolution into a Malignant Lymphoma with Plasmacytoid Features
Overview
Affiliations
In the patient described progressive lymphadenopathy, splenomegaly and interstitial pulmonary disease developed two months after the development of immunoblastic lymphadenopathy. Light microscopic examination of a lymph node biopsy specimen suggested a diagnosis of immunoblastic sarcoma. Evolution of this malignant lymphoma into a leukemic phase allowed detailed studies of the malignant cells by electron microscopy, cytochemical staining and immunologic technics. Evidence is presented that this is a case of malignant lymphoma with plasmacytoid and not lymphoid features. Review of the literature on immunoblastic sarcoma suggests that light microscopy and clinical setting are not sufficient to define a homogeneous clinicopathologic disease.
Xu Y, Jiang X, Zhou Y, Ma M, Wang M, Ying B Front Bioeng Biotechnol. 2021; 9:704077.
PMID: 34447741 PMC: 8383106. DOI: 10.3389/fbioe.2021.704077.
Immunoblastic sarcoma arising in angioimmunoblastic lymphadenopathy.
Olgun N, Tavli V, Kavukcu S, Gogus S, Cevik N Indian J Pediatr. 1993; 60(5):688-92.
PMID: 8157341 DOI: 10.1007/BF02821736.
Schnaidt U, Thiele J, Georgii A Virchows Arch A Pathol Anat Histol. 1980; 389(3):381-95.
PMID: 7456329 DOI: 10.1007/BF00430661.
PLATZER E, Von Roemeling R, Kaduk B, Meinl U Klin Wochenschr. 1981; 59(10):509-16.
PMID: 7241951 DOI: 10.1007/BF01696213.
Malignant lymphomas as tumours of the immune system.
BERARD C, Cossman J, Jaffe E Br J Cancer. 1980; 42(1):1-20.
PMID: 7000112 PMC: 2010473. DOI: 10.1038/bjc.1980.197.